Day One Stock Forward View - Accumulation Distribution

DAWN Stock  USD 11.50  0.34  3.05%   
Day Stock outlook is based on your current time horizon. Although Day One's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Day One's systematic risk associated with finding meaningful patterns of Day One fundamentals over time.
As of today, The RSI of Day One's share price is at 58 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Day One, making its price go up or down.

Momentum 58

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Day One's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Day One Biopharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Day One's stock price prediction:
EPS Estimate Next Quarter
(0.29)
EPS Estimate Current Year
(0.94)
EPS Estimate Next Year
(0.60)
Wall Street Target Price
22.4444
EPS Estimate Current Quarter
(0.28)
Using Day One hype-based prediction, you can estimate the value of Day One Biopharmaceuticals from the perspective of Day One response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Day One using Day One's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Day using crowd psychology based on the activity and movement of Day One's stock price.

Day One Short Interest

An investor who is long Day One may also wish to track short interest. As short interest increases, investors should be becoming more worried about Day One and may potentially protect profits, hedge Day One with its derivative instruments, or be ready for some potential downside.
200 Day MA
7.7149
Short Percent
0.1638
Short Ratio
4.21
Shares Short Prior Month
11.2 M
50 Day MA
9.593

Day Relative Strength Index

Day One Biopharmaceu Hype to Price Pattern

Investor biases related to Day One's public news can be used to forecast risks associated with an investment in Day. The trend in average sentiment can be used to explain how an investor holding Day can time the market purely based on public headlines and social activities around Day One Biopharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Day One's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Day One.

Day One Implied Volatility

    
  1.18  
Day One's implied volatility exposes the market's sentiment of Day One Biopharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Day One's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Day One stock will not fluctuate a lot when Day One's options are near their expiration.

Day One after-hype prediction price

    
  USD 11.5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Day One to cross-verify your projections.

Prediction based on Rule 16 of the current Day contract

Based on the Rule 16, the options market is currently suggesting that Day One Biopharmaceuticals will have an average daily up or down price movement of about 0.0738% per day over the life of the 2026-04-17 option contract. With Day One trading at USD 11.5, that is roughly USD 0.008481 . If you think that the market is fully incorporating Day One's daily price movement you should consider acquiring Day One Biopharmaceuticals options at the current volatility level of 1.18%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-04-17 Day Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Day One's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Day One's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Day One stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Day One's open interest, investors have to compare it to Day One's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Day One is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Day. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Day One Additional Predictive Modules

Most predictive techniques to examine Day price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Day using various technical indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Day One Biopharmaceuticals has current Accumulation Distribution of 112926.0. The accumulation distribution (A/D) indicator shows the degree to which Day One is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Day One Biopharmaceuticals to determine if accumulation or reduction is taking place in the market. This value is adjusted by Day One trading volume to give more weight to distributions with higher volume over lower volume.
Check Day One VolatilityBacktest Day OneInformation Ratio  

Day One Trading Date Momentum

On February 02 2026 Day One Biopharmaceuticals was traded for  11.50  at the closing time. The top price for the day was 11.84  and the lowest listed price was  11.00 . The trading volume for the day was 1.6 M. The trading history from February 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.78% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Day One to competition

Other Forecasting Options for Day One

For every potential investor in Day, whether a beginner or expert, Day One's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Day Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Day. Basic forecasting techniques help filter out the noise by identifying Day One's price trends.

Day One Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Day One stock to make a market-neutral strategy. Peer analysis of Day One could also be used in its relative valuation, which is a method of valuing Day One by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Day One Market Strength Events

Market strength indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By undertsting and applying Day One stock market strength indicators, traders can identify Day One Biopharmaceuticals entry and exit signals to maximize returns.

Day One Risk Indicators

The analysis of Day One's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Day One's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting day stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Day One

The number of cover stories for Day One depends on current market conditions and Day One's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Day One is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Day One's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Day One Short Properties

Day One's future price predictability will typically decrease when Day One's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Day One Biopharmaceuticals often depends not only on the future outlook of the potential Day One's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Day One's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding93.6 M
Cash And Short Term Investments531.7 M
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Historical Fundamental Analysis of Day One to cross-verify your projections.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Biotechnology sector continue expanding? Could Day diversify its offerings? Factors like these will boost the valuation of Day One. Projected growth potential of Day fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Day One data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.52)
Revenue Per Share
1.299
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.19)
Return On Equity
(0.30)
Investors evaluate Day One Biopharmaceu using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Day One's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Day One's market price to deviate significantly from intrinsic value.
It's important to distinguish between Day One's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Day One should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Day One's market price signifies the transaction level at which participants voluntarily complete trades.